Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mark Yap
Observed name:
M. Yap
Institutions:
McKesson (United States),
The US Oncology Network
Observed institutions:
McKesson (United States),
The US Oncology Network
OpenAlex ID:
A5028687337
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices
2015
·
Guru Sonpavde
, Menaka Bhor
, et al.
·
Clinical Genitourinary Cancer
·
52
PDF
First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology Setting
2014
·
Nicholas J. Vogelzang
, Michelle D. Hackshaw
, et al.
·
Clinical Genitourinary Cancer
·
29
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting
2015
·
Nicholas J. Di Bella
, Debajyoti Bhowmik
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
25
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
2015
·
Christopher A. Yasenchak
, Wan-Yu Tseng
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
16
Association Between Treatment Adherence and Response Among Patients With Chronic Myeloid Leukemia (CML) Receiving First-Line TKIs In The Community Setting
2013
·
Nicholas J. Di Bella
, Debajyoti Bhowmik
, et al.
·
Blood
·
2
Outcomes of Advanced Renal Cell Carcinoma Patients (Arcc) Treated with Mammalian Target of Rapamycin Inhibitor (Mtori) Therapy Following First-Line Pazopanib (Paz) in a Us Community Oncology Setting
2014
·
T. Hutson
, M.D. Hackshaw
, et al.
·
Annals of Oncology
·
1
Abiraterone acetate followed by enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) treated in the US Oncology Community Setting.
2015
·
Nicholas J. Vogelzang
, Lina Asmar
, et al.
·
Journal of Clinical Oncology
Patient characteristics and survival outcomes associated with early versus delayed molecular testing in metastatic NSCLC.
2014
·
David A. Smith
, Craig H. Reynolds
, et al.
·
Journal of Clinical Oncology
Outcomes of Advanced Renal Cell Carcinoma Patients (Arcc) Treated with First-Line Pazopanib (Paz) in a Us Community Oncology Setting
2014
·
N. Vogelzang
, M.D. Hackshaw
, et al.
·
Annals of Oncology
An analysis of early molecular testing, time to treatment initiation, and medical resource use in metastatic NSCLC.
2014
·
Craig H. Reynolds
, David A. Smith
, et al.
·
Journal of Clinical Oncology
Economic impact of progressive disease (PD) following frontline therapy in classical Hodgkin lymphoma (HL).
2014
·
Christopher A. Yasenchak
, Wan-Yu Tseng
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
11
Citation count:
125
H-index:
4
I10-index:
4
Year
Topic
Type